General Information of Drug (ID: DM0VQN3)

Drug Name
Ofloxacin Drug Info
Synonyms
Bactocin; DEXTROFLOXACINE; Danoflox; Effexin; Exocin; Exocine; Flobacin; Flodemex; Flotavid; Flovid; Floxal; Floxil; Floxin; Floxstat; Fugacin; Inoflox; Kinflocin; Kinoxacin; Liflox; Loxinter; Marfloxacin; Medofloxine; Mergexin; Novecin; Nufafloqo; OFLX; OFX; Obide; Occidal; Ocuflox; Ofcin; Oflin; Oflocee; Oflocet; Oflocin; Oflodal; Oflodex; Oflodura; Oflox; Ofloxacina; Ofloxacine; Ofloxacino; Ofloxacinum; Ofloxin; Ofus; Onexacin; Operan; Orocin; Otonil; Oxaldin; Pharflox; Praxin; Puiritol; Qinolon; Qipro; Quinolon; Quotavil; Rilox; Sinflo; Tabrin; Taravid; Tariflox; Tarivid; Telbit; Tructum; Viotisone; Visiren; XED; Zanocin; Floxin otic; Ofloxacin Otic; Ofloxacina [DCIT]; Ofloxacine [French]; Ofloxacino [Spanish]; Ofloxacinum [Latin]; Uro Tarivid; DL 8280; HOE 280; O 8757; ORF 18489; PT 01; DL-8280; FLOXIN IN DEXTROSE 5%; FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER; Floxin Otic (TN); HOE-280; Hoe-280; Marfloxacin (TN); O-Flox; ORF-28489; Ocuflox (TN); Ru-43280; WP-0405; Ofloxacin (JP15/USP/INN); Ofloxacin [USAN:BAN:INN:JAN]; Ofloxacin, (S)-Isomer; DL-8280, HOE-280, Exocin, Flobacin, Floxin, Floxil, Monoflocet, Ofloxacin; (+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperaz inyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (+/-)-Floxin; (-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazin-6-carbonsaeure; 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
Indication
Disease Entry ICD 11 Status REF
Acute gonococcal cervicitis Approved [1]
Acute maxillary sinusitis Approved [1]
Anthrax 1B97 Approved [1]
Bacillary dysentery 1A02 Approved [1]
Bacterial infection 1A00-1C4Z Approved [2]
Bronchitis CA20 Approved [1]
Chancroid Approved [1]
Chronic tubotympanic suppurative otitis media Approved [1]
Cystitis GC00 Approved [1]
Latent tuberculosis infection Approved [1]
Malignant otitis externa caused by Pseudomonas aeruginosa Approved [1]
Mycoplasma pneumoniae pneumonia Approved [1]
Pneumonia CA40 Approved [1]
Prostatitis Approved [1]
Pyelonephritis Approved [1]
Staphylococcal pneumonia Approved [1]
Staphylococcus aureus infection Approved [1]
Streptococcal pneumonia Approved [1]
Traveler's diarrhea ME05.1 Approved [1]
Urinary tract infection GC08 Approved [1]
Pneumonia caused by chlamydia Investigative [1]
Therapeutic Class
Antibiotics
Cross-matching ID
PubChem CID
4583
ChEBI ID
CHEBI:7731
CAS Number
82419-36-1
TTD ID
D03NHW
VARIDT ID
DR00517
INTEDE ID
DR2298
ACDINA ID
D00483

Full List of Drug Formulations Containing This Drug

Ofloxacin 400 mg tablet
Company Formulation ID FDA Description
PD-Rx Pharmaceuticals; Teva Pharmaceuticals F15572 Anhydrous lactose; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Polyethylene glycol 400; Polysorbate 80; Hydroxypropyl cellulose (type h); Hypromellose 2910 (3 mpa.s); Hypromellose 2910 (5 mpa.s); Sodium starch glycolate type a potato; Starch, corn
Larken Laboratories F15571 Anhydrous lactose; Magnesium stearate; Titanium dioxide; Polyethylene glycol 400; Polysorbate 80; Hydroxypropyl cellulose; Hypromellose 2208 (3 mpa.s); Hypromellose 2910 (6 mpa.s); Sodium starch glycolate type a potato; Starch, corn
Nivagen Pharmaceuticals F15569 Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Polyethylene glycol 400; Hydroxypropyl cellulose (1200000 mw); Sodium starch glycolate type a potato
Cadila Pharmaceuticals F15570 Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Polyethylene glycol 400; Hypromellose 2910 (5 mpa.s); Hypromelloses; Sodium starch glycolate type a potato; Starch, corn
Dr Reddy's Laboratories F15568 Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Polysorbate 80; Colloidal silicon dioxide; Hypromellose 2910 (5 cps); Polyethylene glycol; Sodium starch glycolate type a potato; Starch, corn
------------------------------------------------------------------------------------
Ofloxacin 200 mg tablet
Company Formulation ID FDA Description
RemedyRepack; Teva Pharmaceuticals F15563 Anhydrous lactose; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Polyethylene glycol 400; Polysorbate 80; Hydroxypropyl cellulose (type h); Hypromellose 2910 (3 mpa.s); Hypromellose 2910 (5 mpa.s); Sodium starch glycolate type a potato; Starch, corn
Nivagen Pharmaceuticals F15561 Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Polyethylene glycol 400; Hydroxypropyl cellulose (1200000 mw); Sodium starch glycolate type a potato
Cadila Pharmaceuticals F15562 Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Polyethylene glycol 400; Hypromellose 2910 (5 mpa.s); Hypromelloses; Sodium starch glycolate type a potato; Starch, corn
Dr Reddy's Laboratories F15560 Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Polysorbate 80; Colloidal silicon dioxide; Hypromellose 2910 (5 cps); Polyethylene glycol; Sodium starch glycolate type a potato; Starch, corn
------------------------------------------------------------------------------------
Ofloxacin 300 mg tablet
Company Formulation ID FDA Description
Teva Pharmaceuticals F15566 Anhydrous lactose; Magnesium stearate; Titanium dioxide; Polyethylene glycol 400; Polysorbate 80; Hydroxypropyl cellulose (type h); Hypromellose 2910 (3 mpa.s); Hypromellose 2910 (5 mpa.s); Sodium starch glycolate type a potato; Starch, corn
Nivagen Pharmaceuticals F15564 Lactose monohydrate; Magnesium stearate; Talc; Titanium dioxide; Polyethylene glycol 400; Hydroxypropyl cellulose (1200000 mw); Sodium starch glycolate type a potato
Cadila Pharmaceuticals F15565 Lactose monohydrate; Magnesium stearate; Talc; Titanium dioxide; Polyethylene glycol 400; Hypromellose 2910 (5 mpa.s); Sodium starch glycolate type a potato; Starch, corn
Dr Reddy's Laboratories F15567 Lactose monohydrate; Magnesium stearate; Titanium dioxide; Polysorbate 80; Colloidal silicon dioxide; Hypromellose 2910 (5 cps); Polyethylene glycol; Sodium starch glycolate type a potato; Starch, corn
------------------------------------------------------------------------------------

References

1 Ofloxacin FDA Label
2 Emerging therapies for the treatment and prevention of otitis media. Expert Opin Emerg Drugs. 2006 May;11(2):251-64.